Identification of treatment-refractory cancer cells in hepatocellular carcinoma tissues
| Project/Area Number |
22591502
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Hamamatsu University School of Medicine |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
稲葉 圭介 浜松医科大学, 医学部, 助教 (10397383)
森田 剛文 浜松医科大学, 医学部, リサーチアシスタント (60464129)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
|---|
| Keywords | 肝臓外科学 / 肝細胞癌 / 治療抵抗性 |
|---|
| Research Abstract |
The initial purpose of this study was to identify the hepatocellular carcinoma cells which are refractory to several therapies, by examining the expression levels of NF-E3-related factor 2 (Nrf2), the main transcription factor for anti-oxidative stress-related genes. We identified Nfr2-rich cells around the cancer-non cancer border region in the resected specimens, although the molecules specifically located in these cells were not observed under mass-spectrometry microscope analysis. Therefore, we examined the expression levels of transporters which are responsible for anti-cancer agent excretion. Western blot and immunohistochemical analysis demonstrated that the posthepatectomic prognosis of patients whose HCC showed low levels of multidrugresistant protein (MDR) 3 was significantly worse. Furthermore, the composition of membranous and cytosolic lipid, phosphatidylcholine, was significantly altered by the intratumor MDR3 levels.
|
Report
(4 results)
Research Products
(11 results)
